Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361825241> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W4361825241 abstract "<div>Abstract<p>Therapies targeting the tyrosine kinase receptor HER2 have significantly improved survival of patients with HER2<sup>+</sup> cancer. However, both <i>de novo</i> and acquired resistance remain a challenge, particularly in the brain metastatic setting. Here we report that, unlike other HER tyrosine kinase receptors, HER2 possesses a binding motif in its cytosolic juxtamembrane region that allows interaction with members of the Ezrin/Radixin/Moesin (ERM) family. Under physiologic conditions, this interaction controls the localization of HER2 in ERM-enriched domains and stabilizes HER2 in a catalytically repressed state. In HER2<sup>+</sup> breast cancers, low expression of Moesin correlated with increased HER2 expression. Restoring expression of ERM proteins in HER2<sup>+</sup> breast cancer cells was sufficient to revert HER2 activation and inhibit HER2-dependent proliferation. A high-throughput assay recapitulating the HER2–ERM interaction allowed for screening of about 1,500 approved drugs. From this screen, we found Zuclopenthixol, an antipsychotic drug that behaved as a Moesin-mimicking compound, because it directly binds the juxtamembrane region of HER2 and specifically inhibits HER2 activation in HER2<sup>+</sup> cancers, as well as activation of oncogenic mutated and truncated forms of HER2. Zuclopenthixol efficiently inhibited HER2<sup>+</sup> breast tumor progression <i>in vitro</i> and <i>in vivo</i> and, more importantly, showed significant activity on HER2<sup>+</sup> brain tumor progression. Collectively, these data reveal a novel class of allosteric HER2 inhibitors, increasing the number of approaches to consider for intervention on HER2<sup>+</sup> breast cancers and brain metastases.</p>Significance:<p>This study demonstrates the functional role of Moesin in maintaining HER2 in a catalytically repressed state and provides novel therapeutic approaches targeting HER2<sup>+</sup> breast cancers and brain metastasis using Moesin-mimicking compounds.</p></div>" @default.
- W4361825241 created "2023-04-05" @default.
- W4361825241 creator A5000874803 @default.
- W4361825241 creator A5009647602 @default.
- W4361825241 creator A5037725448 @default.
- W4361825241 creator A5038994193 @default.
- W4361825241 creator A5040400292 @default.
- W4361825241 creator A5043193254 @default.
- W4361825241 creator A5044540102 @default.
- W4361825241 creator A5045337655 @default.
- W4361825241 creator A5061057486 @default.
- W4361825241 creator A5065452899 @default.
- W4361825241 creator A5065708662 @default.
- W4361825241 creator A5078423175 @default.
- W4361825241 date "2023-03-31" @default.
- W4361825241 modified "2023-09-27" @default.
- W4361825241 title "Data from Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases" @default.
- W4361825241 doi "https://doi.org/10.1158/0008-5472.c.6513291.v1" @default.
- W4361825241 hasPublicationYear "2023" @default.
- W4361825241 type Work @default.
- W4361825241 citedByCount "0" @default.
- W4361825241 crossrefType "posted-content" @default.
- W4361825241 hasAuthorship W4361825241A5000874803 @default.
- W4361825241 hasAuthorship W4361825241A5009647602 @default.
- W4361825241 hasAuthorship W4361825241A5037725448 @default.
- W4361825241 hasAuthorship W4361825241A5038994193 @default.
- W4361825241 hasAuthorship W4361825241A5040400292 @default.
- W4361825241 hasAuthorship W4361825241A5043193254 @default.
- W4361825241 hasAuthorship W4361825241A5044540102 @default.
- W4361825241 hasAuthorship W4361825241A5045337655 @default.
- W4361825241 hasAuthorship W4361825241A5061057486 @default.
- W4361825241 hasAuthorship W4361825241A5065452899 @default.
- W4361825241 hasAuthorship W4361825241A5065708662 @default.
- W4361825241 hasAuthorship W4361825241A5078423175 @default.
- W4361825241 hasBestOaLocation W43618252412 @default.
- W4361825241 hasConcept C101544691 @default.
- W4361825241 hasConcept C121608353 @default.
- W4361825241 hasConcept C126322002 @default.
- W4361825241 hasConcept C142669718 @default.
- W4361825241 hasConcept C1491633281 @default.
- W4361825241 hasConcept C153911025 @default.
- W4361825241 hasConcept C166342909 @default.
- W4361825241 hasConcept C170493617 @default.
- W4361825241 hasConcept C185592680 @default.
- W4361825241 hasConcept C196509110 @default.
- W4361825241 hasConcept C2776292417 @default.
- W4361825241 hasConcept C2777329042 @default.
- W4361825241 hasConcept C2779786085 @default.
- W4361825241 hasConcept C2780246058 @default.
- W4361825241 hasConcept C42362537 @default.
- W4361825241 hasConcept C502942594 @default.
- W4361825241 hasConcept C530470458 @default.
- W4361825241 hasConcept C55493867 @default.
- W4361825241 hasConcept C71924100 @default.
- W4361825241 hasConcept C86803240 @default.
- W4361825241 hasConceptScore W4361825241C101544691 @default.
- W4361825241 hasConceptScore W4361825241C121608353 @default.
- W4361825241 hasConceptScore W4361825241C126322002 @default.
- W4361825241 hasConceptScore W4361825241C142669718 @default.
- W4361825241 hasConceptScore W4361825241C1491633281 @default.
- W4361825241 hasConceptScore W4361825241C153911025 @default.
- W4361825241 hasConceptScore W4361825241C166342909 @default.
- W4361825241 hasConceptScore W4361825241C170493617 @default.
- W4361825241 hasConceptScore W4361825241C185592680 @default.
- W4361825241 hasConceptScore W4361825241C196509110 @default.
- W4361825241 hasConceptScore W4361825241C2776292417 @default.
- W4361825241 hasConceptScore W4361825241C2777329042 @default.
- W4361825241 hasConceptScore W4361825241C2779786085 @default.
- W4361825241 hasConceptScore W4361825241C2780246058 @default.
- W4361825241 hasConceptScore W4361825241C42362537 @default.
- W4361825241 hasConceptScore W4361825241C502942594 @default.
- W4361825241 hasConceptScore W4361825241C530470458 @default.
- W4361825241 hasConceptScore W4361825241C55493867 @default.
- W4361825241 hasConceptScore W4361825241C71924100 @default.
- W4361825241 hasConceptScore W4361825241C86803240 @default.
- W4361825241 hasLocation W43618252411 @default.
- W4361825241 hasLocation W43618252412 @default.
- W4361825241 hasOpenAccess W4361825241 @default.
- W4361825241 hasPrimaryLocation W43618252411 @default.
- W4361825241 hasRelatedWork W1973648303 @default.
- W4361825241 hasRelatedWork W2092691314 @default.
- W4361825241 hasRelatedWork W2415000319 @default.
- W4361825241 hasRelatedWork W2484331045 @default.
- W4361825241 hasRelatedWork W2899407321 @default.
- W4361825241 hasRelatedWork W2910797523 @default.
- W4361825241 hasRelatedWork W3003295592 @default.
- W4361825241 hasRelatedWork W3198517889 @default.
- W4361825241 hasRelatedWork W4324017926 @default.
- W4361825241 hasRelatedWork W4361825241 @default.
- W4361825241 isParatext "false" @default.
- W4361825241 isRetracted "false" @default.
- W4361825241 workType "article" @default.